Adagio Medical Holdings (ADGM) Research & Development (2023 - 2026)
Adagio Medical Holdings (ADGM) posted Research & Development of $2.7 million for Q1 2026, up 22.64% sequentially from $2.2 million in Q4 2025, and down 25.09% YoY from $3.7 million in Q1 2025.
Adagio Medical Holdings (ADGM) Research & Development (2023 - 2026) Analysis & Trends
Adagio Medical Holdings has reported Research & Development for 4 years, with the latest figure at $2.7 million in Q1 2026.
- Quarterly Research & Development fell 25.09% year-over-year to $2.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.7 million (down 13.28% YoY) and the FY2025 annual result came in at $10.6 million, up 129.59% from the prior year.
- Research & Development climbed to $2.7 million in Q1 2026 per ADGM's latest filing, from $2.2 million in the prior quarter.
- Over five years, Research & Development peaked at $4.4 million in Q3 2023 and troughed at $1.2 million in Q3 2024.
- A 4-year average of $2.7 million and a median of $2.8 million in 2025 frame the typical range for Research & Development.
- The sharpest annual moves came in 2024 and 2025: Research & Development sank 72.45% in 2024, then soared 127.94% in 2025.
- Over 4 years, Research & Development stood at $1.8 million in 2023, then slumped by 31.4% to $1.2 million in 2024, then jumped by 83.65% to $2.2 million in 2025, then advanced by 22.64% to $2.7 million in 2026.
- According to Business Quant data, Research & Development over the past three periods registered $2.7 million, $2.2 million, and $2.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Adagio Medical Holdings | 14.41 Mn | 14.41 Mn | - | 2.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.45 Mn |
| Mar 31, 2026 | 2.74 Mn |
| Dec 31, 2025 | 2.24 Mn |
| Sep 30, 2025 | 2.77 Mn |
| Jun 30, 2025 | 1.97 Mn |
| Mar 31, 2025 | 3.66 Mn |
| Sep 30, 2024 | 1.22 Mn |
| Jun 30, 2024 | 2.87 Mn |
| Mar 31, 2024 | 3.47 Mn |
| Dec 31, 2023 | 1.77 Mn |
| Sep 30, 2023 | 4.42 Mn |